Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 3Rectal Neoplasms 2Neoplasms 2Glioma 2Glioblastoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sinonasal Squamous Cell Carcinoma 1Sarcoma 1Radiation Injuries 1Prostatic Neoplasms 1Postoperative Complications 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Melanoma 1Lymphatic Metastasis 1Lung Neoplasms 1Low Anterior Resection Syndrome 1Liposarcoma 1Leiomyosarcoma 1Hepatic Veno-Occlusive Disease 1Head and Neck Neoplasms 1Fatigue 1

Interventions

Oxaliplatin 8Fluorouracil 8pembrolizumab 7Paclitaxel 6Trastuzumab 5Leucovorin 5Capecitabine 5Specimen Handling 4Radiation 4Cisplatin 4Carboplatin 4tislelizumab 3patritumab deruxtecan 3Taxes 3Radiotherapy 3Nivolumab 3ulixertinib 2trastuzumab deruxtecan 2trastuzumab biosimilar HLX02 2durvalumab 2Surgical Procedures, Operative 2Ramucirumab 2Pemetrexed 2PF-05280014 2Ontruzant 2Ogivri 2Magnetic Resonance Spectroscopy 2Irinotecan 2Immunotherapy 2Exercise 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Surgical Procedures, Operative × 30 days × Clear all
NCT07162506 2026-05-29

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Recruiting
120 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT07000253 2026-05-07

OMEC-5

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2/3 Recruiting
290 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡